Kestra Medical Technologies LtdKMTS
Price$27.43Intrinsic value$29.799% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $106.7M+78.4% YoYTTM through 31 Jul 2026
Net Income -$149.9MTTM through 31 Jul 2026
Free Cash Flow -$122.8MTTM through 31 Jul 2026

Margins

Current
Gross Margin52.6%
EBITDA Margin-125.7%
Operating Margin-141.7%
Net Margin-140.4%

Returns

-67.4%ROE
-43.1%ROA

Balance Sheet Health

Debt / Equity0.15x
Current Ratio7.32x
Net Debt-$249.1Mnet cash position
Cash & Equivalents$68.6M

Quality Metrics

Altman Z-Score4.21
Piotroski F-Score4 / 9
FCF Margin-115.0%
Rule of 40-86.6
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'24'25'26
FY2026: $95.1M
Diluted EPS-$2.68TTM
'24'25'26
FY2026: $-2.43

Dividend

No dividend

Capital Allocation

R&D Spend$22.3M
Capex Intensity32.9%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.